PharmaBlock, a global CRDMO, earns the 2024 ACS CMO Excellence in Green Chemistry Award for pioneering sustainable solutions in pharmaceutical manufacturing. Utilizing micropacked bed technology, we optimize oxidation and reductive amination processes, yielding key pharmaceutical intermediates with improved efficiency and safety. PharmaBlock commitment to green chemistry extends to flow chemistry, biocatalysis, and immobilized catalysis, aiming to reduce carbon footprint and enhance manufacturing efficiency. This recognition underscores PharmaBlock's dedication to advancing innovation while promoting environmental sustainability in the pharmaceutical industry.